Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Details)

v3.22.2.2
Restatement of Previously Issued Financial Statements (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2019
Dec. 31, 2021
Dec. 31, 2020
Condensed Consolidated Statement of Operations                
Total Operating Revenue $ 269,453,971 $ 144,586,444   $ 542,998,305 $ 295,884,386      
Medical Expenses 267,448,368 150,380,517   533,269,170 297,005,022      
Total Operating Expenses 1,181,641,128 170,557,507   1,507,353,190 334,843,877      
Operating Loss (912,187,157) (25,971,063)   (964,354,885) (38,959,491)      
Interest Expense, net (2,733,875) (2,369,764)   (5,495,125) (4,494,049)      
Total Other Expenses 9,081,218 (3,493,347)   458,692 (15,155,628)      
Net Loss Attributable to Non-Controlling Interests (748,755,990)     (798,968,740)        
Net Loss (formerly Net Loss Attributable to Controlling Interests) (154,349,949) (29,464,410)   (164,927,453) (54,115,119)      
Condensed Consolidated Statement of Changes in Members' Deficit                
Net Loss 903,105,939 29,464,410 $ 24,650,712 963,896,193 54,115,119      
Balance at the end 108,624,475 (183,308,520) (154,407,902) 108,624,475 (183,308,520)   $ 273,551,441 $ (130,217,705)
Condensed Consolidated Statement of Cash Flows                
Net Loss 903,105,939 29,464,410 $ 24,650,712 963,896,193 54,115,119      
Capitated Revenue                
Condensed Consolidated Statement of Operations                
Total Operating Revenue 267,102,466 141,560,867   536,787,281 290,525,057      
Condensed Consolidated Statement of Cash Flows                
Total RAF adjustments       6,532,954        
Other Patient Service Revenue                
Condensed Consolidated Statement of Operations                
Total Operating Revenue $ 2,351,505 $ 3,025,577   $ 6,211,024 $ 5,359,329      
Class A Preferred Units                
Condensed Consolidated Statement of Changes in Members' Deficit                
Preferred return   8.00% 8.00%   8.00% 8.00%    
Class A and Class D Units                
Condensed Consolidated Statement of Changes in Members' Deficit                
Preferred return       8.00%        
As Previously Reported                
Condensed Consolidated Statement of Operations                
Total Operating Revenue   $ 151,418,598     $ 302,982,979      
Medical Expenses   150,679,717     297,570,662      
Total Operating Expenses   170,856,707     335,409,517      
Operating Loss   (19,438,108)     (32,426,538)      
Interest Expense, net   (4,406,240)     (8,487,374)      
Total Other Expenses   (5,529,823)     (19,148,953)      
Net Loss Attributable to Non-Controlling Interests   (1,959,421)     (5,241,713)      
Net Loss (formerly Net Loss Attributable to Controlling Interests)   (23,008,510)     (46,333,778)      
Condensed Consolidated Statement of Changes in Members' Deficit                
Net Loss   (24,967,931) $ (26,607,560)   (51,575,491)      
Balance at the end   (146,395,455) (122,918,168)   (146,395,455)     (97,661,735)
Condensed Consolidated Statement of Cash Flows                
Net Loss   (24,967,931) (26,607,560)   (51,575,491)      
Health Plan Settlements Receivable/Premiums Receivable         (5,320,861)      
As Previously Reported | Capitated Revenue                
Condensed Consolidated Statement of Operations                
Total Operating Revenue   147,159,665     294,860,130      
As Previously Reported | Other Patient Service Revenue                
Condensed Consolidated Statement of Operations                
Total Operating Revenue   4,258,933     8,122,849      
As Previously Reported | Class A Preferred Units                
Condensed Consolidated Statement of Changes in Members' Deficit                
Preferred Return at 8%   926,852 890,612   1,817,564      
As Previously Reported | Class A and Class D Units                
Condensed Consolidated Statement of Cash Flows                
Class A and Class D Preferred Returns         3,993,325      
Network Adjustments                
Condensed Consolidated Statement of Operations                
Net Loss Attributable to Non-Controlling Interests   1,959,421     5,241,713      
Net Loss (formerly Net Loss Attributable to Controlling Interests)   (1,959,421)     (5,241,713)      
Preferred Returns Adjustments                
Condensed Consolidated Statement of Operations                
Interest Expense, net   2,036,476     3,993,325      
Total Other Expenses   2,036,476     3,993,325      
Net Loss (formerly Net Loss Attributable to Controlling Interests)   2,036,476     3,993,325      
Condensed Consolidated Statement of Changes in Members' Deficit                
Net Loss   2,036,476 1,956,848   3,993,325      
Balance at the end   6,743,106 5,633,581   6,743,106     4,567,346
Condensed Consolidated Statement of Cash Flows                
Net Loss   2,036,476 1,956,848   3,993,325      
Preferred Returns Adjustments | Class A Preferred Units                
Condensed Consolidated Statement of Changes in Members' Deficit                
Preferred Return at 8%   (926,852) (890,612)   (1,817,564)      
Preferred Returns Adjustments | Class A and Class D Units                
Condensed Consolidated Statement of Cash Flows                
Class A and Class D Preferred Returns         (3,993,325)      
Class A Units Adjustments                
Condensed Consolidated Statement of Changes in Members' Deficit                
Balance at the end   (43,656,170) (43,656,269)   (43,656,170)     (43,656,270)
Revenue Adjustments                
Condensed Consolidated Statement of Operations                
Total Operating Revenue   (6,832,155)     (7,098,593)      
Medical Expenses   (299,200)     (565,640)      
Total Operating Expenses   (299,200)     (565,640)      
Operating Loss   (6,532,955)     (6,532,953)      
Net Loss (formerly Net Loss Attributable to Controlling Interests)   (6,532,955)     (6,532,953)      
Condensed Consolidated Statement of Changes in Members' Deficit                
Net Loss   (6,532,955)     (6,532,953)      
Balance at the end     6,532,954         6,532,954
Condensed Consolidated Statement of Cash Flows                
Net Loss   (6,532,955)     (6,532,953)      
Health Plan Settlements Receivable/Premiums Receivable         6,532,953      
Revenue Adjustments | Capitated Revenue                
Condensed Consolidated Statement of Operations                
Total Operating Revenue   (5,598,799)     (4,335,073)      
Revenue Adjustments | Other Patient Service Revenue                
Condensed Consolidated Statement of Operations                
Total Operating Revenue   (1,233,356)     (2,763,520)      
As Restated                
Condensed Consolidated Statement of Operations                
Total Operating Revenue   144,586,443     295,884,386      
Medical Expenses   150,380,517     297,005,022      
Total Operating Expenses   170,557,507     334,843,877      
Operating Loss   (25,971,063)     (38,959,491)      
Interest Expense, net   (2,369,764)     (4,494,049)      
Total Other Expenses   (3,493,347)     (15,155,628)      
Net Loss (formerly Net Loss Attributable to Controlling Interests)   (29,464,410)     (54,115,119)      
Condensed Consolidated Statement of Changes in Members' Deficit                
Net Loss   (29,464,410) (24,650,712)   (54,115,119)      
Balance at the end   (183,308,519) (154,407,902)   (183,308,519)     $ (130,217,705)
Condensed Consolidated Statement of Cash Flows                
Net Loss   (29,464,410) $ (24,650,712)   (54,115,119)      
Health Plan Settlements Receivable/Premiums Receivable         1,212,092      
As Restated | Capitated Revenue                
Condensed Consolidated Statement of Operations                
Total Operating Revenue   141,560,866     290,525,057      
As Restated | Other Patient Service Revenue                
Condensed Consolidated Statement of Operations                
Total Operating Revenue   $ 3,025,577     $ 5,359,329